The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2025

Filed:

Aug. 12, 2019
Applicant:

Inflazome Limited, Dublin, IE;

Inventors:

Matthew Cooper, Cambridge, GB;

David Miller, Cambridge, GB;

Angus MacLeod, Cambridge, GB;

Jonathan Shannon, Nottingham, GB;

Jokin Carrillo Arregui, Nottingham, GB;

Jimmy Van Wiltenburg, Groningen, NL;

Jochem Theodoor Van Herpt, Groningen, NL;

Assignee:

INFLAZOME LIMITED, Dublin, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07C 311/30 (2006.01); C07D 205/04 (2006.01); C07D 207/48 (2006.01); C07D 243/08 (2006.01); C07D 295/26 (2006.01); C07D 487/04 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07C 311/30 (2013.01); C07D 205/04 (2013.01); C07D 207/48 (2013.01); C07D 243/08 (2013.01); C07D 295/26 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01);
Abstract

The present invention relates to compounds of formula (I): wherein Q is selected from O or S; Rand Rare each independently hydrogen or an optionally substituted hydrocarbyl group, or Rand Rtogether with the nitrogen atom to which they are attached may form a 3- to 12-membered optionally substituted cyclic group; and Ris a cyclic group substituted at the position, wherein Rmay optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.


Find Patent Forward Citations

Loading…